✦ LIBER ✦

Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C

✍ Scribed by Takuro Hayata; Yoshiyuki Nakano; Kaname Yoshizawa; Takeshi Sodeyama; Kendo Kiyosawa

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 806 KB
Volume: 13
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840130603

No coin nor oath required. For personal study only.

✦ Synopsis

We investigated the effects of interferon therapy on hepatocyte human leukocyte antigen class I and class I1 antigen expression and intrahepatic lymphocyte subsets in patients with chronic viral hepatitis B (n = 11) and C (n = 10). Interferon-a was administered intramuscularly in doses ranging from 3 to 18 million international units daily for 4 wk. Liver biopsy spqcimens were obtained just before and immediately after treatment, and the specimens were stained by the indirect immunoperoxidase method for evaluation of human leukocyte antigen expression and lymphocyte subsets. Before therapy, no significant difference was noted between hepatitis B and C in human leukocyte antigen class I antigen expression on hepatocytes or in the lymphocyte subsets in the intralobular and portal areas. After interferon-a treatment, hepatocyte expression of human leukocyte antigen class I antigens and serum fi2-microglobulin levels were virtually unchanged in chronic viral hepatitis C patients, but both were increased in chronic viral hepatitis B patients. Human leukocyte antigen class I1 antigens were not expressed during treatment. The mean number of intralobular CD3+ and CD8+ cells and the mean serum ALT level decreased significantly in chronic viral hepatitis C patients (p < 0.05) but not in chronic viral hepatitis 8 patients. The mean number of intralobular CD4+ cells was unaffected by interferon therapy in both groups. In all 21 patients, the changes in CD8 + cell numbers paralleled the changes in serum ALT levels. Our findings suggest that T-cell cytotoxicity may play an important role in hepatocyte damage in both chronic viral hepatitis C and chronic viral hepatitis B and that the response to interferon-a differs in these two types of hepatitis. (HEPATOLOGY 1991;13:1022-1028.) Infection with HBV or hepatitis C virus (HCV) can lead to such chronic liver diseases as hepatitis, cirrhosis or HCC (1-5).

Thus eradicating these viruses from patients with

📜 SIMILAR VOLUMES

Recombinant human γ-interferon in patien

Recombinant human γ-interferon in patients with chronic active hepatitis B: Pharmacokinetics, tolerance and biological effects

✍ Patrick Marcellin; Marie-Anne Loriot; Nathalie Boyer; Michéle Martinot-Peignoux; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB

Pharmacokinetics, tolerance and biological effects of human recombinant y-interferon were studied in 12 patients with chronic active hepatitis B. Serum concentrations of y-interferon were measured by radioimmunoassay in four patients after a subcutaneous injection of 10 million U (0.6 mg); the peak

Effects of ribavirin on intrahepatic and

Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients

✍ Dr. John Koskinas; Christopher Tibbs; Mohammed G. Saleh; Dr. Leila M. M. B. Pere 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

## Abstract Response to ribavirin therapy (1,000‐1,200 mg/day for 6 months) was evaluated in nine patients with chronic hepatitis C virus (HCV) infections who had previously failed to respond to a 6‐month course of alpha‐interferon. All had chronic active hepatitis with elevated serum aminotransfer

Effects of immunosuppressive therapy wit

Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis

✍ Reginald G. Hanson; Marion G. Peters; Jay H. Hoofnagle 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 856 KB

Relationship Between Expression of Hepat

Relationship Between Expression of Hepatitis B Virus Antigens in Isolated Hepatocytes and Autologous Lymphocyte Cytotoxicity in Patients with Chronic Hepatitis B Virus Infection

✍ Nikolai V. Naumov; Mario Mondelli; Graeme J. M. Alexander; Richard S. Tedder; Ad 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

Previous studies demonstrated that peripheral blood lymphocytes are cytotoxic to autologous hepatocytes in patients with chronic hepatitis B virus infection. We examined whether cytotoxicity is specifically directed against hepatocytes expressing HBsAg or HBcAg. Viral antigens were detected by immun

Prevalence and impact of occult hepatiti

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca

Effect of interferon administration on s

Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C

✍ Kazuaki Chayama; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Toyomi Matsumoto; Yo 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

Hepatitis C virus RNA as detected by reverse transcription and nested polymerase chain reaction was monitored in 16 patients with chronic hepatitis C treated with interferon. Hepatitis C virus R N A became undetectable after 4 to 8 wk of interferon administration in 13 of the 16 patients. During 6 m